Halo Therapeutics

Developer of therapeutics for the treatment of Covid-19

placeBristol, England, United Kingdom calendar_todayFounded 2020 groups1 employees language halo-therapeutics.com

Registered entities

Innovation

5 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 35 times.

YearFilings
20132
20141
20151
20161
20172
20181
20211
20221
20232
20252

Investor mix

6 investors on record; lead investors include Development Bank of Wales, Science Angel Syndicate, KBA Group.

Investor typeCountShare
Private equity233%
Angel & family office117%
Other / undisclosed350%
Coming soon